27,547 Shares in Zoetis Inc. (NYSE:ZTS) Purchased by Cypress Asset Management Inc. TX

Cypress Asset Management Inc. TX bought a new stake in Zoetis Inc. (NYSE:ZTS - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 27,547 shares of the company's stock, valued at approximately $4,593,000. Zoetis comprises 1.1% of Cypress Asset Management Inc. TX's investment portfolio, making the stock its 27th biggest position.

Several other institutional investors and hedge funds also recently bought and sold shares of ZTS. JPMorgan Chase & Co. lifted its holdings in Zoetis by 10.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,916,539 shares of the company's stock worth $569,834,000 after buying an additional 279,092 shares in the last quarter. Janney Montgomery Scott LLC grew its position in Zoetis by 65.7% during the 4th quarter. Janney Montgomery Scott LLC now owns 172,111 shares of the company's stock worth $28,042,000 after purchasing an additional 68,227 shares during the last quarter. Mutual Advisors LLC grew its position in Zoetis by 31.4% during the 4th quarter. Mutual Advisors LLC now owns 3,691 shares of the company's stock worth $625,000 after purchasing an additional 882 shares during the last quarter. Secure Asset Management LLC grew its position in Zoetis by 39.8% during the 4th quarter. Secure Asset Management LLC now owns 2,297 shares of the company's stock worth $374,000 after purchasing an additional 654 shares during the last quarter. Finally, Brighton Jones LLC lifted its stake in shares of Zoetis by 180.4% in the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company's stock worth $754,000 after acquiring an additional 2,978 shares during the period. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Zoetis

In other news, EVP Roxanne Lagano sold 326 shares of the stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $170.00, for a total value of $55,420.00. Following the completion of the sale, the executive vice president now directly owns 15,781 shares of the company's stock, valued at $2,682,770. This represents a 2.02% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Willie M. Reed sold 1,210 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $166.14, for a total value of $201,029.40. Following the completion of the transaction, the director now owns 11,245 shares in the company, valued at $1,868,244.30. This represents a 9.71% decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is owned by corporate insiders.

Zoetis Stock Performance

Shares of NYSE:ZTS traded down $1.06 on Wednesday, reaching $165.20. 1,723,724 shares of the company's stock were exchanged, compared to its average volume of 2,525,518. The business's 50-day moving average is $156.53 and its two-hundred day moving average is $164.69. The firm has a market capitalization of $73.55 billion, a price-to-earnings ratio of 30.20, a PEG ratio of 2.78 and a beta of 0.94. The company has a quick ratio of 1.08, a current ratio of 1.75 and a debt-to-equity ratio of 1.09. Zoetis Inc. has a fifty-two week low of $139.70 and a fifty-two week high of $200.33.

Zoetis (NYSE:ZTS - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.40 by $0.08. The firm had revenue of $2.22 billion during the quarter, compared to analyst estimates of $2.20 billion. Zoetis had a net margin of 26.86% and a return on equity of 53.82%. Zoetis's revenue was up 1.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.38 EPS. As a group, equities research analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 3rd. Shareholders of record on Friday, July 18th will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.21%. The ex-dividend date of this dividend is Friday, July 18th. Zoetis's payout ratio is 35.91%.

Wall Street Analyst Weigh In

Several analysts recently commented on ZTS shares. Piper Sandler raised their price objective on shares of Zoetis from $205.00 to $210.00 and gave the company an "overweight" rating in a research note on Monday, May 12th. Barclays boosted their price objective on shares of Zoetis from $242.00 to $244.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. UBS Group lowered their target price on shares of Zoetis from $189.00 to $170.00 and set a "neutral" rating for the company in a report on Wednesday, May 7th. Stifel Nicolaus decreased their price objective on shares of Zoetis from $180.00 to $165.00 and set a "buy" rating for the company in a research note on Monday, April 14th. Finally, Morgan Stanley decreased their price objective on shares of Zoetis from $243.00 to $238.00 and set an "overweight" rating for the company in a research note on Friday, February 14th. One research analyst has rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, Zoetis presently has a consensus rating of "Buy" and an average price target of $212.75.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.